| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ACO2
|
aconitase 2, mitochondrial
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADRA1B
|
adrenoceptor alpha 1B
|
|
AFP
|
alpha-fetoprotein
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGR2
|
anterior gradient 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIF1
|
allograft inflammatory factor 1
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALB
|
albumin
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
ALPP
|
alkaline phosphatase, placental
|
|
ALPPL2
|
alkaline phosphatase, placental-like 2
|
|
APOB
|
apolipoprotein B
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AQP9
|
aquaporin 9
|
|
AR
|
androgen receptor
|
|
ARAF
|
A-Raf proto-oncogene, serine/threonine kinase
|
|
AREG
|
amphiregulin
|
|
ARID5A
|
AT rich interactive domain 5A (MRF1-like)
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARTN
|
artemin
|
|
ATF3
|
activating transcription factor 3
|
|
ATP5O
|
ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIK
|
BCL2-interacting killer (apoptosis-inducing)
|
|
BMP15
|
bone morphogenetic protein 15
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRCA1
|
breast cancer 1, early onset
|
|
C3
|
complement component 3
|
|
C5AR2
|
complement component 5a receptor 2
|
|
CACNA1E
|
calcium channel, voltage-dependent, R type, alpha 1E subunit
|
|
CACNB3
|
calcium channel, voltage-dependent, beta 3 subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALR
|
calreticulin
|
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CARM1
|
coactivator-associated arginine methyltransferase 1
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCNE1
|
cyclin E1
|
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex)
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD82
|
CD82 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CECR6
|
cat eye syndrome chromosome region, candidate 6
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA4
|
cholinergic receptor, nicotinic, alpha 4 (neuronal)
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNB2
|
cholinergic receptor, nicotinic, beta 2 (neuronal)
|
|
CHRNB4
|
cholinergic receptor, nicotinic, beta 4 (neuronal)
|
|
CKB
|
creatine kinase, brain
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLDN4
|
claudin 4
|
|
CLDN8
|
claudin 8
|
|
CLU
|
clusterin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CREBBP
|
CREB binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTTN
|
cortactin
|
|
CXADR
|
coxsackie virus and adenovirus receptor
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DCN
|
decorin
|
|
DEFB4A
|
defensin, beta 4A
|
|
DEK
|
DEK proto-oncogene
|
|
DHRS9
|
dehydrogenase/reductase (SDR family) member 9
|
|
DIO3
|
deiodinase, iodothyronine, type III
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ELOVL6
|
ELOVL fatty acid elongase 6
|
|
EP300
|
E1A binding protein p300
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ESRRG
|
estrogen-related receptor gamma
|
|
EZR
|
ezrin
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHL2
|
four and a half LIM domains 2
|
|
FKBPL
|
FK506 binding protein like
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FMO1
|
flavin containing monooxygenase 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA1
|
forkhead box A1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FZR1
|
fizzy/cell division cycle 20 related 1 (Drosophila)
|
|
GADD45B
|
growth arrest and DNA-damage-inducible, beta
|
|
GDF9
|
growth differentiation factor 9
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GH1
|
growth hormone 1
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPS2
|
G protein pathway suppressor 2
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GPX3
|
glutathione peroxidase 3
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRIN1
|
glutamate receptor, ionotropic, N-methyl D-aspartate 1
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
GRM3
|
glutamate receptor, metabotropic 3
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3
|
|
GUCY1B3
|
guanylate cyclase 1, soluble, beta 3
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
H2AFX
|
H2A histone family, member X
|
|
HADH
|
hydroxyacyl-CoA dehydrogenase
|
|
HDAC1
|
histone deacetylase 1
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXA10
|
homeobox A10
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B12
|
hydroxysteroid (17-beta) dehydrogenase 12
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
HSDL2
|
hydroxysteroid dehydrogenase like 2
|
|
HSF2
|
heat shock transcription factor 2
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL17A
|
interleukin 17A
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KAT5
|
K(lysine) acetyltransferase 5
|
|
KCNG1
|
potassium channel, voltage gated modifier subfamily G, member 1
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KDR
|
kinase insert domain receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRC3
|
killer cell lectin-like receptor subfamily C, member 3
|
|
KRT18
|
keratin 18, type I
|
|
KRT8
|
keratin 8, type II
|
|
LCOR
|
ligand dependent nuclear receptor corepressor
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIF
|
leukemia inhibitory factor
|
|
LLGL2
|
lethal giant larvae homolog 2 (Drosophila)
|
|
LPO
|
lactoperoxidase
|
|
LTF
|
lactotransferrin
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBD4
|
methyl-CpG binding domain protein 4
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MCM3
|
minichromosome maintenance complex component 3
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MCM6
|
minichromosome maintenance complex component 6
|
|
MCM7
|
minichromosome maintenance complex component 7
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED1
|
mediator complex subunit 1
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MTA3
|
metastasis associated 1 family, member 3
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYH10
|
myosin, heavy chain 10, non-muscle
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NDUFB8
|
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa
|
|
NELFB
|
negative elongation factor complex member B
|
|
NFE2L1
|
nuclear factor, erythroid 2-like 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFE2L3
|
nuclear factor, erythroid 2-like 3
|
|
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NKD1
|
naked cuticle homolog 1 (Drosophila)
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NNMT
|
nicotinamide N-methyltransferase
|
|
NOG
|
noggin
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPPA
|
natriuretic peptide A
|
|
NPPC
|
natriuretic peptide C
|
|
NPVF
|
neuropeptide VF precursor
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR1I3
|
nuclear receptor subfamily 1, group I, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NTF3
|
neurotrophin 3
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OLFM1
|
olfactomedin 1
|
|
ORM1
|
orosomucoid 1
|
|
ORM2
|
orosomucoid 2
|
|
OVGP1
|
oviductal glycoprotein 1, 120kDa
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P4HB
|
prolyl 4-hydroxylase, beta polypeptide
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAWR
|
PRKC, apoptosis, WT1, regulator
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor)
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PER1
|
period circadian clock 1
|
|
PGR
|
progesterone receptor
|
|
PHB
|
prohibitin
|
|
PHB2
|
prohibitin 2
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha)
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLK1
|
polo-like kinase 1
|
|
PNOC
|
prepronociceptin
|
|
PNRC2
|
proline-rich nuclear receptor coactivator 2
|
|
POMC
|
proopiomelanocortin
|
|
POU1F1
|
POU class 1 homeobox 1
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1R9B
|
protein phosphatase 1, regulatory subunit 9B
|
|
PPRC1
|
peroxisome proliferator-activated receptor gamma, coactivator-related 1
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRDX5
|
peroxiredoxin 5
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRL
|
prolactin
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROS1
|
protein S (alpha)
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER1
|
prostaglandin E receptor 1 (subtype EP1), 42kDa
|
|
PTGER2
|
prostaglandin E receptor 2 (subtype EP2), 53kDa
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTHLH
|
parathyroid hormone-like hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTMA
|
prothymosin, alpha
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RB1
|
retinoblastoma 1
|
|
RBP4
|
retinol binding protein 4, plasma
|
|
RCOR1
|
REST corepressor 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RGS20
|
regulator of G-protein signaling 20
|
|
RGS9
|
regulator of G-protein signaling 9
|
|
RHOA
|
ras homolog family member A
|
|
RNF4
|
ring finger protein 4
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
S100G
|
S100 calcium binding protein G
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SDC3
|
syndecan 3
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFN
|
stratifin
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT1
|
sirtuin 1
|
|
SIRT2
|
sirtuin 2
|
|
SKIL
|
SKI-like proto-oncogene
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC11A2
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2
|
|
SLC18A2
|
solute carrier family 18 (vesicular monoamine transporter), member 2
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
|
SLC22A1
|
solute carrier family 22 (organic cation transporter), member 1
|
|
SLC22A12
|
solute carrier family 22 (organic anion/urate transporter), member 12
|
|
SLC22A24
|
solute carrier family 22, member 24
|
|
SLC22A3
|
solute carrier family 22 (organic cation transporter), member 3
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC24A3
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
|
SLC30A3
|
solute carrier family 30 (zinc transporter), member 3
|
|
SLC30A9
|
solute carrier family 30 (zinc transporter), member 9
|
|
SLC31A1
|
solute carrier family 31 (copper transporter), member 1
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC7A4
|
solute carrier family 7, member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLC9A2
|
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2
|
|
SLC9A4
|
solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
SP1
|
Sp1 transcription factor
|
|
SPATA13
|
spermatogenesis associated 13
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STC1
|
stanniocalcin 1
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
SULT1A1
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1
|
|
SULT1A3
|
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TBX21
|
T-box 21
|
|
TCL1B
|
T-cell leukemia/lymphoma 1B
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFF1
|
trefoil factor 1
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TH
|
tyrosine hydroxylase
|
|
THBS1
|
thrombospondin 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TNF
|
tumor necrosis factor
|
|
TP53
|
tumor protein p53
|
|
TRH
|
thyrotropin-releasing hormone
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TRRAP
|
transformation/transcription domain-associated protein
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TSHB
|
thyroid stimulating hormone, beta
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TXNRD1
|
thioredoxin reductase 1
|
|
TYR
|
tyrosinase
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UBE3A
|
ubiquitin protein ligase E3A
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A10
|
UDP glucuronosyltransferase 1 family, polypeptide A10
|
|
UGT1A3
|
UDP glucuronosyltransferase 1 family, polypeptide A3
|
|
UGT1A7
|
UDP glucuronosyltransferase 1 family, polypeptide A7
|
|
UGT1A8
|
UDP glucuronosyltransferase 1 family, polypeptide A8
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15
|
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7
|
|
UQCRC2
|
ubiquinol-cytochrome c reductase core protein II
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VIM
|
vimentin
|
|
WT1
|
Wilms tumor 1
|
|
ZNF366
|
zinc finger protein 366
|
